Adarx Pharmaceuticals Insider Bought Shares Worth $1,045,772, According to a Recent SEC Filing

MT newswire2026/09/30 21:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

05:32 PM EDT, 09/30/2026 (MT Newswires) -- Erez Chimovits, Director, on September 28, 2026, executed a purchase for 61,516 shares in Adarx Pharmaceuticals (ADRX) for $1,045,772. Following the Form 4 filing with the SEC, Chimovits has control over a total of 9,292,025 common shares of the company, with 9,292,025 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1802369/000094787126000912/xslF345X05/ownership.xml

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

According to Freddie Mac data, the 30-year fixed mortgage rate has risen to 7.4%, the highest level in nearly three years. Data from real estate brokerage Redfin shows that the volume of existing home pending sales in September fell 4% month-on-month, marking the largest single-month drop in over three years and hitting the lowest level since 2014. Nearly one-fifth of sellers have reduced prices, and the home purchase contract cancellation rate has reached a record high of 14.5%. Inventory levels have risen to the highest since March 2020, but high financing costs continue to constrain transactions.

华尔街见闻•2026/10/12 20:41